Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Food Scene
Community Directory
Community Service
Restaurant Guide
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Horizons
Outdoor Guide
Progress
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2022 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BGNE
Recent news which mentions BGNE
< Previous
1
2
3
4
5
Next >
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
January 26, 2023
Tickers
AZN
BGNE
JNJ
Tags
Recent Press Releases
JNJ
BGNE
From
Motley Fool
4 Analysts Have This to Say About BeiGene
January 20, 2023
Tickers
BGNE
Tags
Benzinga
BGNE
Market News
From
Benzinga
Draganfly To Rally Around 87%? Here Are 10 Other Analyst Forecasts For Friday
January 20, 2023
Tickers
BGNE
BILL
DK
DPRO
Tags
Benzinga
Small Cap
DPRO
From
Benzinga
FDA Approves BeiGene's Brukinsa For Chronic Lymphocytic Leukemia
January 20, 2023
Tickers
BGNE
Tags
General
Health Care
Briefs
From
Benzinga
One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.
January 18, 2023
Tickers
ABBV
AZN
BGNE
JNJ
Tags
JNJ
ABBV
BGNE
From
MarketWatch
U.S.-listed Chinese stocks rise as China eases COVID-19 lockdown restrictions
December 27, 2022
Tickers
BABA
BEKE
BGNE
BIDU
Tags
LI
BIDU
XPEV
From
MarketWatch
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Tickers
BGNE
BIIB
CDTX
CHRS
Tags
CHRS
Biopharma
CDTX
From
Benzinga
Zymeworks Cancer Candidate Shows Objective Response Of 41% In Bile Duct Cancer
December 19, 2022
Tickers
BGNE
ZYME
Tags
Trading Ideas
Briefs
News
From
Benzinga
BeiGene Earnings Perspective: Return On Capital Employed
December 12, 2022
Tickers
BGNE
Tags
Benzinga
BZI/ROCE
BGNE
From
Benzinga
PayPal To Rally Around 47%? Here Are 10 Other Price Target Changes For Monday
December 12, 2022
Tickers
ACHC
BA
BGNE
CCL
Tags
CCL
Markets
MU
From
Benzinga
What 5 Analyst Ratings Have To Say About BeiGene
December 12, 2022
Tickers
BGNE
Tags
Benzinga
Market News
BZI/AAR
From
Benzinga
Will Investors Notice Exciting Sign On BeiGene's Chart?
December 06, 2022
Tickers
BGNE
Tags
Markets
Movers
Market News
From
Benzinga
Why Shares of BeiGene Were Up Wednesday
December 01, 2022
Tickers
BGNE
Tags
Market News
BGNE
Recent Press Releases
From
Motley Fool
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session
November 30, 2022
Tickers
AGLE
API
ATAT
BBW
Tags
ZH
CANG
QTT
From
Benzinga
Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday
November 30, 2022
Tickers
API
ATAT
AVDL
BBW
Tags
Movers
LU
WDAY
From
Benzinga
Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket
November 30, 2022
Tickers
AKAN
ASPN
BGNE
BXRX
Tags
XPEV
XFOR
CNEY
From
Benzinga
Quant Ratings Updated on 59 Stocks
November 29, 2022
Tickers
BGNE
BNTX
CZR
FDX
Tags
Market News
NFLX
CZR
From
InvestorPlace
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
November 23, 2022
Tickers
AGBA
API
ARDX
ATNM
Tags
SATX
SLGC
MLAB
From
Benzinga
What 4 Analyst Ratings Have To Say About BeiGene
November 10, 2022
Tickers
BGNE
Tags
BGNE
BZI/AAR
Analyst Ratings
From
Benzinga
Tesla, Amazon, Coupang, Rivian, Beigene: Musk's Share Sale, Antitrust Lawsuit, Earnings Grab Retail Investors' Eyeballs
November 09, 2022
Tickers
AAPL
AMZN
BGNE
CPNG
Tags
News
Market News
electric vehicles
From
Benzinga
Is This Chinese Pharmaceutical Stock Worth the Risk?
November 03, 2022
Tickers
BGNE
Tags
Recent Press Releases
Market News
BGNE
From
Motley Fool
Jazz Obtains Exclusive Rights To Zymeworks' Cancer Candidate In Almost $2B Biobuck Deal
October 19, 2022
Tickers
BGNE
JAZZ
ZYME
Tags
BGNE
Small Cap
Benzinga
From
Benzinga
New Drugs Approvals Bring No Relief for Ailing Innovent Bio
October 18, 2022
Tickers
ASIA
BGNE
LLY
SNY
Tags
contributors
SNY
Asia
From
Benzinga
European Heath Agency's Committee Backs Approving BeiGene's Brukinsa In Leukemia Setting
October 14, 2022
Tickers
BGNE
Tags
Benzinga
BGNE
Movers
From
Benzinga
Analyst Ratings for BeiGene
October 13, 2022
Tickers
BGNE
Tags
Benzinga
BGNE
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Tickers
ABMD
ADMA
ALB
AMCR
Tags
EMN
Benzinga
HOLX
From
Benzinga
BeiGene's Brukinsa Shows Superior Progression-Free Survival Versus JNJ's Treatment
October 12, 2022
Tickers
BGNE
JNJ
Tags
Market News
News
Briefs
From
Benzinga
UK's NICE Recommends BeiGene's Cancer Drug For Rare Form Of Blood Cancer
September 20, 2022
Tickers
BGNE
Tags
General
Health Care
Biotech
From
Benzinga
BeiGene's Tislelizumab Shows Non-Inferiority In Overall Survival, Safety Vs Standard Treatment In Solid Tumors
September 12, 2022
Tickers
BAYRY
BGNE
Tags
BGNE
Biotech
BAYRY
From
Benzinga
Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay
September 09, 2022
Tickers
ASIA
BGNE
LLY
PFE
Tags
Market News
News
General
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.